Liquidia Corp (LQDA)
10.41
+0.26
(+2.56%)
USD |
NASDAQ |
Nov 22, 12:14
Liquidia Total Liabilities (Quarterly): 142.37M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 142.37M |
| June 30, 2024 | 114.64M |
| March 31, 2024 | 110.86M |
| December 31, 2023 | 71.04M |
| September 30, 2023 | 63.64M |
| June 30, 2023 | 60.94M |
| March 31, 2023 | 47.28M |
| December 31, 2022 | 38.78M |
| September 30, 2022 | 37.53M |
| June 30, 2022 | 36.98M |
| March 31, 2022 | 38.14M |
| December 31, 2021 | 28.46M |
| September 30, 2021 | 27.34M |
| June 30, 2021 | 25.36M |
| Date | Value |
|---|---|
| March 31, 2021 | 25.54M |
| December 31, 2020 | 28.45M |
| September 30, 2020 | 25.83M |
| June 30, 2020 | 26.56M |
| March 31, 2020 | 31.01M |
| December 31, 2019 | 33.89M |
| September 30, 2019 | 32.69M |
| June 30, 2019 | 32.62M |
| March 31, 2019 | 36.40M |
| December 31, 2018 | 30.73M |
| September 30, 2018 | 29.37M |
| June 30, 2018 | 33.70M |
| March 31, 2018 | 33.24M |
| December 31, 2017 | 48.54M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
25.36M
Minimum
Jun 2021
142.37M
Maximum
Sep 2024
50.73M
Average
37.25M
Median
Total Liabilities (Quarterly) Benchmarks
| United Therapeutics Corp | 1.022B |
| Arcturus Therapeutics Holdings Inc | 108.79M |
| Paragon 28 Inc | 162.58M |
| Tonix Pharmaceuticals Holding Corp | 20.78M |
| AIM ImmunoTech Inc | 10.68M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 252.89M |
| Shareholders Equity (Quarterly) | 110.52M |
| Current Ratio | 6.330 |